Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3–4 prostate cancer: Impact of the EORTC22863 and RTOG 85-31 and 92-02 trials-Reference-Cited by-同舟云学术

Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3–4 prostate cancer: Impact of the EORTC22863 and RTOG 85-31 and 92-02 trials

Published:2013-06 Issue:3 Volume:107 Page:366-371
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Tran Eric,Paquette Matthew,Pickles Tom,Jay Justin,Hamm Jeremy,Liu Mitchell,Lim Jan,Keyes Mira,Kwan Winkle,Tyldesley Scott

Funder

Michael Smith Foundation for Health Research

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

2. Duration of androgen suppression in the treatment of prostate cancer;Bolla;N Engl J Med,2009

3. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study;Bolla;Lancet Oncol,2010

4. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy;D’Amico;J Clin Oncol,2008

5. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma – long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study;Frontiers in Oncology;2022-01-03

2. Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review;PLOS ONE;2021-06-18

3. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients;Urologia Internationalis;2018-11-08

4. ADT in Combination with Radiation Therapy for Clinically Localized Prostate Cancer;Hormone Therapy and Castration Resistance of Prostate Cancer;2018

5. The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy;Radiotherapy and Oncology;2017-08